Hims & Hers Joins Nvidia, Tesla, Apple in Most Active Stock Options: Options Chatter
Leerink Partners Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $42
Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took It By Surprise -- Barrons.com
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%
Novo Nordisk Cuts 2025 Outlook. But Why Are Its Shares Rising?
Express News | Hims & Hers : Deutsche Bank Raises Target Price to $43 From $38
